Detalhe da pesquisa
1.
Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study.
Scand J Gastroenterol
; 59(4): 425-432, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156792
2.
The need for surgery in pediatric patients with inflammatory bowel disease treated with biologicals.
Int J Colorectal Dis
; 39(1): 58, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661931
3.
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia.
Scand J Gastroenterol
; 58(1): 25-33, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996928
4.
Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseases.
Scand J Gastroenterol
; 55(1): 34-40, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841064
5.
Impact of ulcerative colitis on patients' lives: results of the Finnish extension of a global ulcerative colitis narrative survey.
Scand J Gastroenterol
; 54(7): 869-875, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31282225
6.
Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice.
Biologicals
; 58: 50-56, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755369
7.
The impacts of an inflammatory bowel disease nurse specialist on the quality of care and costs in Finland.
Scand J Gastroenterol
; 53(12): 1463-1468, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30600722
8.
High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).
Scand J Gastroenterol
; 53(2): 158-167, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258369
9.
Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.
Scand J Gastroenterol
; 52(3): 284-290, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27806638
10.
A New Digital Health Program for Patients With Inflammatory Bowel Disease: Preliminary Program Evaluation.
JMIR Form Res
; 7: e39331, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115598
11.
Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
Inflamm Bowel Dis
; 27(11): 1747-1755, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529314
12.
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey.
Therap Adv Gastroenterol
; 14: 17562848211006678, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995580
13.
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
J Clin Med
; 10(13)2021 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209880
14.
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
Inflamm Bowel Dis
; 24(11): 2442-2451, 2018 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788318
15.
Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
J Crohns Colitis
; 9(1): 33-40, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052347
16.
Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission.
Inflamm Bowel Dis
; 20(6): 1021-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24798636
17.
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
J Crohns Colitis
; 7(9): 730-5, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23182163
18.
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents.
Inflamm Bowel Dis
; 18(11): 2011-7, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223566